↓ Skip to Main Content

thasso

the new generation glocalized patient network in theragenomic and personalized medicine and individualized drug safety

search: thasso

  • Log in

Main Navigation

  • englishenglish
    • englishenglish
    • deutschdeutsch
    • françaisfrançais
  • thasso
  • thasso post
  • thasso community
    • thasso: community
    • thasso: forum
    • thasso: patient groups
    • thasso: simple chat
    • thasso: video chat
    • thasso: online meetings (ZOOM)
  • thasso toolbox
    • theragenomics: useful links
    • theragenomics: survey at thasso
      • survey participants
    • theragenomics: biomarkers
    • theragenomics: companion tests
    • theragenomics: drug labels with annotated information
    • theragenomics: targeted therapies
    • theragenomics: drugs and genes
    • theragenomics: allele-related guideline information
    • theragenomics: videos
    • drugs: interactions
    • drugs: general information
    • drugs: adverse reactions
    • drugs: risk evaluation and mitigation strategies (REMS)
  • thasso academy
    • health authorities
      • European Medicines Agency (EMA)
      • American Food & Drug Administration (FDA)
      • Swissmedic
      • FDA Ghana
      • NAFDAC Nigeria
      • CDSCO India
      • The Medicines Control Council (MCC), South Africa
      • China Food & Drug Administration (CFDA)
      • Health Canada
    • public domain
      • Clinical Pharmacogenetics Implementation Consortium
      • ACMG Genetic Test Fact Sheets
      • Public Health Genomics Knowledge Base
      • The Human Diagnosis Project
      • Phenotypes And Genotypes Database
      • Genetic Alliance UK
      • Genetics Generation
      • Front Line Genomics
      • Alliance for Cancer Gene Therapy (ACGT)
      • EUPATI The European Patients’ Academy on Therapeutic Innovation
      • European Patient Forum
      • Uppsala Monitoring Center
      • World Health Organisation (WHO)
      • von Hippel Lindau Syndrome (VHL)
      • Cerebral Palsy Symptoms
      • Mesothelioma Fund
      • Multiple Myeloma Research Foundation
      • Open Source Pharma (OSP, Medicine for All)
    • theragenomics worldwide
      • The Human Heredity and Health in Africa (H3Africa)
      • The Asia Cohort Consortium
      • GenomeAsia 100K
    • patient & consumer health
      • ThinkGenetic
      • Consumer Health Labs
      • Exercise & Heart Disease
      • UCSF: Eating right for your heart
      • Hormones Matter
      • Living with Arthritis
      • Living with Cannabis
      • Yum of China (Foods)
    • digital therapeutics in theragenomic medicine
      • Digital Therapeutics Alliance (DTA)
      • Digital Health Alliance
    • miscellaneous
      • Partners Health Care / Personalized Medicine
      • Worst Pills / Best Pills
      • Pharmagenomics Research Network
      • Mayo Clinic: Personalized Medicine
      • Patient Power
      • Patient Opinion (UK)
      • Drug Injury Watch (Tom Lamb)
      • Ways To Fund Cancer Treatments
      • MedScape India
      • Swiss Academy of Medical Sciences
      • IDICAP: An Integrated Drug Intervention for Cancer Panel
      • PanDrugs
      • Soccer Genomics
    • companies
      • BionTech
      • FDNA (Face2Gene Home)
      • IONIS Pharmaceuticals
      • Boehringer Ingelheim Home
      • Bristol-Myers Squipp Home
      • Glaxo Home
      • Novartis Home
      • Roche Home
      • AstraZeneca Home
      • Merck Home
      • Gilead Home
      • Takeda Home
      • Janssen Home
      • Novo Nordisk Home
      • Amgen Home
      • Moderna
    • products
      • Axicabtagene ciloleucel (Yescarta)
      • Ledipasvir/Sofosbuvir (Harvoni)
      • Sofosbuvir (Sovaldi)
      • Pembrolizumab (Keytruda)
      • Nivolumab (Opdivo)
      • Sekukinumab (Cosentyx)
      • Rivaroxaban (Xarelto)
      • Valsartan/Amlodipin/HCT (Exforge/HCT)
      • Aripiprazole (Abilify)
      • Rosuvastatin (Crestor)
      • Flibanserin (Addyi)
      • Onasemnogene abeparvovec-xioi (Zolgensma)
      • Voretigene neparvovec (Luxturna)
  • thasso – about
    • vision
    • background
    • the apomediary patient
    • disclaimer
    • policies
    • contact
  • donations $
Home › Posts tagged Aneurysm

Tag: Aneurysm

Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors

By Joseph Gut - thasso Posted on August 26, 2020 Posted in Adverse Drug Reaction [ADR], Regulatory Announcement, Thasso Post, Theragenomic Medicine No Comments
Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors

August 26 2020 –  Vascular endothelial growth factor (VEGF), originally known as vascular permeability factor (VPF)  is a signal protein produced by cells that stimulates the formation of blood vessels. VEGF is a sub-family of growth factors, the platelet-derived growth factor …

Increased Risk Of Aneurysms And Artery Dissections With VEGF Inhibitors Read more »

Tagged with: Age-Related Macular Degeneration, Aneurysm, Angiogenesis, Artery Dissection, Axitinib (Inlyta), Bevacizumab [Avastin], Bevacizumab-awwb (Mvasi), Bevacizumab-bvzr (Zirabev), Cabozantinib (Cabometyx), Cabozantinib (Cometriq), Cancer, DrugInjuryWatch.com, FDA Adverse Event Reporting System (FAERS), Individual Case Safety Report (ICSR), Lenvatinib (Lenvima), Medicines and Healthcare products Regulatory Agency (MHRA), Nintedanib [Ofev], Pazopanib [Votrient], Ponatinib (Iclusig), Ramucirumab [Cyramza], Regorafenib (Stivarga), Retina, Sorafenib tosylate (Nexavar), Sunitinib malate (Sutent), Tom Lamb, Vandetanib (Caprelsa), Vascular Endothelial Growth Factor (VEGF), Vasculogenesis, VEGF Inhibitor, VigiBase, Ziv-aflibercept (Zaltrap)

Optional: Social Subscribe/Login

FacebookGoogleVkontakteTwitterInstagramLinkedInAmazonSalesforceWindowslive

logo


thasso: donate

We need your help. Please support the development of thasso through donations. Thank you.    Nous avons besoin de votre aide. S'il vous plaît, vous pouvez soutenir le développement de thasso grâce à des dons. Merci.    Wir brauchen Ihre Hilfe. Bitte unterstützen Sie die Entwicklung von thasso durch Spenden. Vielen Dank.

thasso: conditions

thasso: newest tweets

Tweets by thasso_info

 

RSS FDA press releases

  • Coronavirus (COVID-19) Update: January 19, 2021 January 19, 2021
  • FDA Marks Historic Public Health Milestone with Finalization of Two Key Rules for Companies Seeking to Market New Tobacco Products January 19, 2021
  • Coronavirus (COVID-19) Update: January 15, 2021 January 15, 2021
  • Federal judge enters consent decree against Washington state juice processor January 15, 2021
  • FDA Warns Firms to Remove Unauthorized E-liquid Products from Market in First Letters Issued to Manufacturers that Did Not Submit Premarket Applications by Deadline January 15, 2021

RSS FDA MedWatch

  • Boston Scientific Announces LOTUS Edgeâ„¢ Aortic Valve System Voluntary Recall and Product Discontinuation January 11, 2021
  • Genetic Variants of SARS-CoV-2 May Lead to False Negative Results with Molecular Tests for Detection of SARS-CoV-2 - Letter to Clinical Laboratory Staff and Health Care Providers January 8, 2021
  • Fresenius Kabi Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP Due to the Presence of Particulate Matter January 8, 2021
  • Wear Face Masks with No Metal During MRI Exams: FDA Safety Communication January 7, 2021
  • Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication January 4, 2021

RSS EMA Press releases

  • Extra dose from vials of Comirnaty COVID-19 vaccine, , 08/01/2021 January 20, 2021
  • Global regulators highlight key role of healthcare professionals in fostering confidence in COVID-19 vaccines, , 19/01/2021 January 19, 2021
  • Cyberattack on EMA - update 5, , 15/01/2021 January 15, 2021
  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 11-14 January 2021, PRAC, 15/01/2021 January 15, 2021
  • Cyberattack on EMA - update 4, , 12/01/2021 January 12, 2021

RSS random genetics

  • Researchers identify new genetic disorder that affects brain, craniofacial skeleton January 20, 2021
    Researchers at the National Institutes of Health have discovered a new genetic disorder characterized by developmental delays and malformations of the brain, heart and facial features. Named linkage-specific-deubiquitylation-deficiency-induced embryonic defects syndrome (LINKED), it is caused by a mutated version of the OTUD5 gene, which interferes with key molecular steps in embryo development. The findings indicate […]
  • Genome editing to treat human retinal degeneration January 20, 2021
    Gene editing therapies, including CRISPR-Cas systems, offer the potential to correct mutations causing inherited retinal degenerations, a leading cause of blindness. Technological advances in gene editing, continuing safety concerns, and strategies to overcome these challenges are highlighted in the peer-reviewed journal Human Gene Therapy.
  • Research identifies genetic risk factor for stroke January 19, 2021
    A team of Geisinger researchers has identified a common genetic variant as a risk factor for stroke, especially in patients older than 65.
  • Scientists find new mechanism of cancer formation January 19, 2021
    A team of scientists at the National University of Singapore (NUS), led by Dr. Polly Leilei Chen from the Cancer Science Institute of Singapore and Yong Loo Lin School of Medicine at NUS, has discovered a previously unknown mechanism of cancer formation, the understanding of which may lead to more effective treatment.
  • Specific genes increase the risk of bedwetting January 19, 2021
    In a large-scale study of Danish children and young people, researchers from Aarhus University have for the first time found genetic variants that increase the risk of nocturnal enuresis—commonly known as bedwetting or nighttime incontinence. The findings provide completely new insights into the processes in the body causing this widespread phenomenon.

Recent Comments

  • Avatar David Walliams on Is genetic testing of value for ALS patients?: “CURED FROM GENITAL HERPES More than 5 years ago I was in pain with this deadly herpes virus, A few…” Nov 7, 16:08
  • Avatar Raul Malkovic on Is genetic testing of value for ALS patients?: “HOW MY WIFE GOT CURED FROM ALS Below is how i got a cure for my wife who suffered from Amyotrophic Lateral Sclerosis…” Nov 6, 21:18
  • Avatar Pamela Erickson on Is genetic testing of value for ALS patients?: “My husband was diagnosed with ALS (amyotrophic lateral sclerosis) when he was 63 years old 4 years ago. The Rilutek…” Aug 13, 13:04
  • thassodotcom thassodotcom on Unlucky women with BIA-ALCL: An update: “The Therapeutic Goods Agency (TGA) of Australia has just issued a hazard alert concerning the risk of breast implant-associated anaplastic…” Aug 4, 09:17
  • thassodotcom thassodotcom on Tofacitinib (Xeljanz): Dangers of blood clots in the lungs and of death: “According to its Drug Safety Communication from 07/26/2019, the FDA has approved new warnings about an increased risk of blood…” Aug 4, 08:40

Tag Cloud

Adverse Drug Reaction (ADR) African American Allelic Variant Allelic Variants American Food & Drug Administration (FDA) American Food & Drug Administration (FDA) Boxed Warning Breast Cancer Canagliflozin (Invokana) Cancer Children Clinical Trial Committee for Medicinal Products for Human Use (CHMP) Companion Test Diabetes Empagliflozin [Jardiance] Epidermal Growth Factor Receptor (EGFR) Erectile Dysfunction Ethnicity European Medicine Agency (EMA) European Medicines Agency (EMA) Gene Therapy Genetic Background Genetic Predisposition Genetic Testing Health Canada Non-Small Cell Lung Cancer (NSCLC) Obesity Pembrolizumab [Keytruda] Personalized Medicine Phenotype Progressive Multifocal Leukoencephalopathy (PML) Rare Disease Risk Evaluation and Mitigation Strategy (REMS) Schizophrenia Sildenafil [Viagra] Sodium-Glucose Cotransporter-2 (SGLT2) Stevens Johnson Syndrome [SJS] Targeted Therapy ThassoBase Thasso Post Theragenomic Medicine Toxic Epidermal Necrolysis (TEN) Type 2 Diabetes Vemurafenib [Zelboraf]

thasso

thasso, the new generation glocalized patient network in theragenomic and personalized medicine and individualized drug safety provides access to and sharing of personal and professional information in health and disease to individual patients, to patient subgroups, and to large patient populations worldwide

keys

Social Media, Social Network, Theragenomic Medicine, Social Medicine, Personalized Medicine, Genomic Medicine, Participative Medicine, Targeted Therapy, Individualized Therapy, Personalized Therapy, Individualized Drug Safety, Personalized Drug Safety, Genetic Variants, Allelic Variants, Genotypes, Molecular Phenotypes, Clinical Phenotypes, Companion Test, Heart Disease, Arthritis, Asthma, Diabetes, Hypertension, Malignant Tumors, Breast Cancer, Lung Cancer, Skin Cancer, Erectile Dysfunction, Crowd Sourcing, Patient Sourcing, Participative Sourcing, Collective Experience, Collective Community Wisdom, Apomediary Patient Expert, Patient Cloud,

meta

  • Register
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
© 2021 thasso | Powered by Responsive Theme